IP Library Granted Patent US 10,669,592
Granted Patent B2
US 10,669,592 · App. 16/286,476 · Granted Jun 2, 2020

Electrochemical detection of bacterial and/or fungal infections

Inventors: Lisa Lynn Freeman-Cook (Carlsbad, CA); Christine J. Shaw (San Diego, CA); Milena Iacobelli Martinez (Vista, CA); Anna Maria Al-Khouri (San Diego, CA); Bradley Adam Brown (San Marcos, CA); John Jay Harvey (San Marcos, CA)
Assignee: Clinical Micro Sensors, Inc.
C12Q1/689B01L3/5023B01L3/5027C12Q1/686C12Q1/6853C12Q1/6895G01N27/3277G01N27/48B01L2300/0627B01L2300/0819C12Q2600/16G16H15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,669,592
App. No.
16/286,476
Granted
Jun 2, 2020
Kind
B2
Abstract

The present disclosure relates to methods and devices for amplifying a plurality of targets in a single PCR run while distinguishing between clinically relevant amplification and amplification from other sources such as from background contamination. The methods and devices further enable discrimination between gram-positive, gram-negative and fungal infections as wells as identify antimicrobial resistance genes. When applying the methods and devices of the invention, the species or genus of an infection(s), and genus of a fungal co-infection(s) or category of bacterial (gram-positive or negative) co-infection(s) are identified. Species identification of co-infections can also be achieved. Further, when applying the methods and devices of the invention, organisms which are likely to be contaminating organisms from a blood draw are identified.

Claims (40)

1. A method for processing at least a first and second patient sample comprising:

a) receiving a first and second patient sample;

b) receiving a test order from a hospital laboratory information system (LIS) for the first and second patient sample;

c) processing the first and second patient sample in a target analyte detection instrument wherein the target analyte detection instrument is directly linked to a LIS interchange;

d) generating a first result identifying at least one pathogen in the first patient sample processed by the target analyte detection instrument and generating a second result identifying at least one value for the second patient sample processed by the target analyte detection instrument; and

e) automatically reporting the first result to the LIS interchange by the target analyte detection instrument directly to the LIS interchange and queuing the second result on the target analyte detection instrument for manual reporting based on the at least one value of the second result.

2. The method of claim 1 , wherein the at least one value of the second result is an invalid result caused by an instrument error or a detection error.

3. The method of claim 1 , wherein the at least one value of the second result is an invalid result caused by three or more targets being detected in the second patient sample.

4. The method of claim 1 , wherein the LIS interchange connects to more than one hospital LIS.

5. The method of claim 1 , wherein the at least one pathogen in the first patient sample processed is a viable gram-positive bacteria and the first patient sample comprises viable gram-positive bacteria and non-viable gram-positive bacteria.

6. The method of claim 5 , wherein the target analyte detection instrument performs a single detuned multiplex end-point polymerase chain reaction (PCR) on the first patient sample, the PCR comprising about 30 to about 35 cycles.

7. A method for processing at least a first and second patient sample comprising:

a) receiving a first and second patient sample;

b) receiving a test order from a hospital LIS;

c) processing the first and second patient sample according to the test order, in a target analyte detection instrument wherein the target analyte detection instrument is directly linked to a LB interchange;

d) generating a first result by the target analyte detection instrument that identifies at least one pathogen in the first patient sample and generating a second result from the target analyte detection instrument that identifies at least one value for the second patient sample processed;

e) converting the first result to a first detection report and converting the second result to a second detection report; and

f) automatically reporting by the target analyte detection instrument the first detection report to the LB interchange and queuing the second detection result on the target analyte detection instrument for manual reporting based on the at least one value of the second result.

8. The method of claim 7 , further comprising manually applying comments to the first detection report.

9. The method of claim 7 , further comprising manually applying comments to the second detection report.

10. A method for processing at least a first and second patient sample comprising:

a) receiving a first and second patient sample;

b) receiving a test order from a hospital LIS;

c) processing the first and second patient sample in a target analyte detection instrument wherein the target analyte detection instrument is directly linked to a LIS interchange;

d) generating a first detection report identifying at least one pathogen in the first patient sample processed by the target analyte detection instrument and generating a second detection report identifying at least one value for the second patient sample processed by the target analyte detection instrument;

e) automatically sending the first detection report by the target analyte detection instrument to the LIS interchange and queuing the second detection report on the target analyte detection instrument for manual reporting based on the at least one value of the second result;

f) converting the first detection report to a first physician test result report; and

g) reporting the first physician test result report to a hospital LIS using the LIS interchange.

11. The method of claim 10 , wherein the first detection report is in a CSV format and the first physician test result report is in an HL7 or ASTM format.

12. The method of claim 10 , wherein the at least one pathogen in the first patient sample is a blood stream pathogen that causes or is suspected of causing sepsis.

13. The method of claim 10 , wherein the physician test order is converted from an HL7 or ASTM format to a CSV format.

14. The method of claim 10 , wherein the second detection report identifies at least one pathogen as Propionibacterium acnes, Staphylococcus epidermidis, Micrococcus, Lactobacillus or Corynebacterium.

15. The method of claim 10 , wherein the first detection report identifies the presence of a resistance gene present in the at least one pathogen in the first patient sample.

16. The method of claim 10 , wherein the at least one pathogen is a human pathogen, and wherein the first patient sample further comprises a contaminating pathogen.

17. The method of claim 10 , wherein the first physician test result report comprises information on detected targets, non-detected targets, invalid results and/or control data.

18. The method of claim 10 , wherein the first detection report comprises information on detected targets, non-detected targets, invalid results and/or control data.

19. The method of claim 10 , wherein the target analyte detection instrument sends an alert if stability time is violated for the first patient sample.

20. The method of claim 19 , wherein the target analyte detection instrument performs a single detuned multiplex end-point polymerase chain reaction (PCR) on the first patient sample, the PCR comprising about 30 to about 35 cycles.

21. The method of claim 1 , wherein the LIS interchange automatically reports the first result to the hospital LIS.

22. The method of claim 7 , wherein the LIS interchange automatically reports the first detection report to the hospital LIS.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2019
From: BROWN, BRADLEY ADAM; MARTINEZ, MILENA IACOBELLI; FREEMAN-COOK, LISA LYNN; HARVEY, JOHN JAY; SHAW, CHRISTINE J.; AL-KHOURI, ANNA MARIA
To: CLINICAL MICRO SENSORS, INC. DBA GENMARK DIAGNOSTICS, INC
Reel/Frame 048460/0595 →
Continuity (4)
Continuation 16054960 · Aug 3, 2018
Continuation 15828074 · Nov 30, 2017
Continuation 15686001 · Aug 24, 2017
Related Publication 20190185915A1 · Jun 20, 2019